Sponsor:
Tarveda Therapeutics
Code:
NCT03221400
Conditions
Carcinoma
Endometrial Adenocarcinoma
Neoplasms
Squamous Cell Carcinoma of the Anus
Adenocarcinoma of the Pancreas
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
PEN-866 Sodium
fluorouracil
Folinic acid
Niraparib
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by Tarveda Therapeutics on 2022-02-17.